PDE4B and Cognitive impairment: In the present study, we demonstrated for the first time that the PDE4B inhibitor A33 prevented cognitive impairment and Aβ deposition in an animal model of AlD, primarily by alleviating neuroinflammatory reactions in the hippocampus via the activation of the PDE4B/cAMP/PKA signaling pathway.